On May 1, 2018 Aurinia Pharmaceuticals Inc., (NASDAQ: AUPH / TSX: AUP) reported that it will release its first quarter 2018 financial results on Thursday, May 10, 2018, after the market closes (Press release, Aurinia Pharmaceuticals, MAY 1, 2018, View Source [SID1234526546]). Aurinia’s management will host a conference call to discuss the company’s first quarter 2018 financial results and provide a general business update.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The conference call and webcast is scheduled for May 10, 2018 at 4:30pm EDT. In order to participate in the conference call, please dial +1-877-407-9170 (Toll-free U.S. & Canada). An audio webcast can be accessed under "News/Events" through the "Investors" section of the Aurinia corporate website at www.auriniapharma.com. A replay of the webcast will be available on Aurinia’s website.